Home โบ Expertise โบ Lung & Mediastinal Cancer
Early Detection. Accurate Diagnosis. Better Treatment Outcomes. โ Fellowship-trained expertise in minimally invasive lung cancer surgery at KG Hospital, Coimbatore. Uniportal VATS, Robotic Surgery, and advanced thoracic oncology.
๐ Book a Consultation
Understanding Lung Cancer
Lung cancer is the most common cause of cancer-related death worldwide โ and one of the most treatable cancers when caught early. It arises when cells in the lung grow abnormally and form a tumour that can invade surrounding tissue and spread to other organs.
The lung is also a common site of secondary (metastatic) cancer โ when cancers from the breast, colon, kidney, or other organs spread to the lung. The management of primary lung cancer and pulmonary metastases differs significantly.
As a Lung Cancer Specialist with fellowship training at Tata Memorial Hospital, Mumbai and Shanghai Pulmonary Hospital, China, Dr. Prabhakaran U manages the full spectrum of lung cancer โ from early-stage resectable disease to complex advanced cases โ using the most modern surgical and multidisciplinary approaches available.
Recognising Lung Cancer
One of the greatest challenges with lung cancer is that early-stage tumours often cause no symptoms at all. The lung has no pain receptors โ a tumour can grow silently for months. By the time symptoms appear, the cancer may have advanced. This is why screening and prompt investigation of any respiratory symptoms is so important.
โ ๏ธ Do not wait: Any of these symptoms lasting more than 3 weeks in an adult over 40 โ particularly a smoker โ warrants urgent investigation with a chest X-ray and CT scan. Early diagnosis transforms outcomes.
Staging determines the extent of cancer spread and guides treatment decisions. Lung cancer is staged from I to IV:
Cancer confined to the lung โ no lymph node involvement
5-year survival: 70โ90% with surgery
Cancer spread to nearby lymph nodes within the lung
5-year survival: 50โ65% with surgery
Cancer spread to central chest lymph nodes or adjacent structures
5-year survival: 15โ35%
Cancer spread to the other lung or distant organs
5-year survival: <10%
Surgical Treatment Options
Surgery remains the only curative treatment for early-stage lung cancer. Dr. Prabhakaran performs all types of lung cancer surgery โ from minimally invasive keyhole techniques to complex open resections:
Removal of an entire lung lobe through a single 3โ4 cm incision โ the most advanced keyhole lung surgery available. Fellowship trained at Shanghai Pulmonary Hospital, China. Hospital stay 2โ3 days. Less pain, faster recovery, equivalent cancer control to open surgery.
Removal of only the affected segment of the lung โ preserving more lung function than lobectomy. Increasingly preferred for smaller tumours (under 2 cm) and patients with limited lung reserve. Same single-port keyhole approach.
Removal of a small wedge-shaped piece of lung containing the tumour โ for small peripheral lesions or patients with poor lung function. Quickest operation with fastest recovery. Also used for diagnostic biopsy of lung nodules.
Robotic-Assisted Thoracic Surgery using the Da Vinci X system โ offering 3D magnified vision up to 10ร, superior instrument articulation, and tremor-free precision. Particularly valuable for complex resections near central vessels. Dr. Prabhakaran is a Certified Console Surgeon.
Traditional open chest surgery โ reserved for very complex tumours involving major vessels, the chest wall, or cases requiring sleeve resection (removal and reconstruction of airways). Dr. Prabhakaran performs open surgery when minimally invasive approaches are not appropriate.
Surgical removal of secondary lung deposits from other primary cancers (colorectal, sarcoma, kidney, breast). Selected patients with limited, resectable lung metastases benefit from surgery โ offering improved survival in carefully chosen cases.
Mediastinal Cancer
The mediastinum is the central compartment of the chest โ the space between the two lungs containing the heart, great vessels, trachea, oesophagus, thymus gland, and lymph nodes. Tumours arising in this space are called mediastinal tumours or masses.
Mediastinal tumours are relatively uncommon but can cause significant symptoms by compressing adjacent structures. They range from completely benign cysts to aggressive malignancies.
Surgery is the primary treatment for most mediastinal tumours. Dr. Prabhakaran performs:
Multidisciplinary approach: All mediastinal tumour cases are discussed at a tumour board involving oncologists, radiologists, and pathologists before a surgical plan is finalised. Treatment decisions are never made by the surgeon alone.
Beyond Surgery
When surgery alone is not sufficient, or when lung cancer is diagnosed at an advanced stage, other treatments are used โ often in combination with surgery:
Used before surgery (neoadjuvant โ to shrink tumours), after surgery (adjuvant โ to reduce recurrence risk), or as primary treatment for advanced or small cell lung cancer.
Oral pills targeting specific genetic mutations (EGFR, ALK, ROS1, BRAF). Dramatically effective in selected patients โ often with fewer side effects than traditional chemotherapy.
Drugs that activate the immune system to fight cancer (PD-1/PDL-1 inhibitors). Can achieve remarkable, durable responses in some patients with advanced lung cancer.
Stereotactic Ablative Radiotherapy โ high-dose, precisely targeted radiation for early-stage lung cancer in patients unfit for surgery. Excellent results in carefully selected patients.
Endobronchial ultrasound (EBUS), navigational bronchoscopy for biopsy, and bronchoscopic interventions for airway obstruction caused by central tumours.
For advanced disease โ symptom control, pleural effusion drainage, pain management, and supporting quality of life alongside active cancer treatment.
Dr. Prabhakaran's role: As a surgical oncologist, Dr. Prabhakaran focuses on the surgical component of lung cancer treatment. He works closely with medical oncologists, radiation oncologists, pulmonologists, and radiologists to ensure each patient receives a comprehensive, personalised treatment plan โ not just surgery.
Prevention & Early Detection
The best way to cure lung cancer is to detect it before it causes symptoms. Low-Dose CT (LDCT) screening is now recommended for high-risk individuals and has been shown to reduce lung cancer mortality by 20โ24% in large clinical trials.
Annual LDCT screening is a simple, low-radiation scan that takes minutes. If you or a family member falls into the high-risk category, discuss screening with Dr. Prabhakaran at your consultation.
Stop smoking today. Quitting smoking at any age reduces lung cancer risk. After 10 years of cessation, risk falls to approximately half that of a current smoker. It is the single most impactful action a smoker can take.
Common Questions
Related Expertise